Insights on ADHD diagnosis, treatment, research, and living well with neurodiversity.
Bupropion (brand name Wellbutrin) is the most studied non-stimulant medication for ADHD after atomoxetine. For people who cannot tolerate stimulants, have comorbid depression, or have a history of substance misuse, bupropion is a clinically meaningful alternative.
Misophonia — literally "hatred of sound" — is a condition in which specific sounds trigger intense, disproportionate emotional and physiological responses: rage, disgust, anxiety, or panic. The sounds involved are typically pattern-based, repetitive, and often human-generated: chewing, swallowing, breathing, sniffing, tapping, or pen clicking. For people with misophonia, these sounds do not merely irritate — they provoke a near-automatic, overwhelming aversive reaction that can make eating with others, working in open offices, or living with family members profoundly difficult.
ADHD in women is underdiagnosed, underresearched, and frequently misunderstood — and the consequences of that are significant. Women with ADHD receive their diagnosis an average of five years later than men, often only after years of being told they have anxiety, depression, or simply "stress." By the time many women are correctly identified, they've developed a thick layer of compensatory strategies, shame, and burnout that makes the condition harder to see and harder to treat.
Executive dysfunction is one of the most important — and least understood — aspects of ADHD. It's the reason a highly intelligent person can't reliably pay their bills on time. It's why someone can write a brilliant essay but can't start it until the night before it's due. It's the gap between knowing what needs to be done and being able to do it.
When a child with ADHD seems not to listen, it is rarely wilful disobedience. The neurological reality is that ADHD impairs working memory — the system that holds incoming information while the brain processes it — and disrupts the filtering of irrelevant stimuli. An instruction that competed with a more stimulating distraction may simply never have registered. Understanding this distinction changes how parents and teachers approach the problem.
The tools a clinical psychologist uses to assess ADHD have expanded considerably since the first standardised rating scales appeared in the 1960s. Today a comprehensive evaluation draws from structured interviews, normed behaviour rating scales, computerised attention tests, and neuropsychological batteries. Knowing which tools are considered gold standard — and why some popular tests add less diagnostic value than their reputation suggests — helps both clinicians and patients understand the quality of an evaluation they are conducting or receiving.
The Adult ADHD Self-Report Scale (ASRS) is the most widely used screening tool for ADHD in adults worldwide, developed by the World Health Organization in collaboration with Harvard Medical School researchers. It is free, takes under 5 minutes, and has been validated in population studies across multiple countries. Understanding what the ASRS measures — and crucially, what it does not — is essential for interpreting your result accurately.
IQ testing occupies a contested space in ADHD assessment. It is routinely included in comprehensive neuropsychological evaluations, generates numbers that feel precise and authoritative, and yet its role in confirming or ruling out ADHD is widely misunderstood by patients and sometimes by the clinicians ordering it. Here is a clear-eyed account of what IQ testing adds to an ADHD evaluation — and what it does not.